Holen Sie sich die Stockscreener-App
22.83
0.17%
-0.03
Schlusskurs vom Vortag:
$22.86
Offen:
$23.37
24-Stunden-Volumen:
1.25M
Relative Volume:
0.31
Marktkapitalisierung:
$4.17B
Einnahmen:
$644.86M
Nettoeinkommen (Verlust:
$196.05M
KGV:
23.27
EPS:
0.9812
Netto-Cashflow:
$317.50M
1W Leistung:
+10.03%
1M Leistung:
+10.83%
6M Leistung:
-50.91%
1J Leistung:
-62.50%
1-Tages-Spanne:
$22.67
$23.57
1-Wochen-Bereich:
$20.98
$23.57
52-Wochen-Spanne:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
22.83 | 4.00B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
194.02 | 31.31B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
68.94 | 13.55B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.99 | 10.82B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
97.98 | 7.97B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
90.66 | 6.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Herabstufung | Truist | Buy → Hold |
| 2026-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity Inc (DOCS) Shares Surge 4.6% -- What GF Score of 82 Tel - GuruFocus
How Doximity Inc. Class A (DOCS) Affects Rotational Strategy Timing - Stock Traders Daily
Tranche Update on Doximity, Inc.'s Equity Buyback Plan announced on February 5, 2026. - marketscreener.com
Doximity, Inc. (DOCS) Stock Analysis: Navigating Healthcare’s Digital Frontier with Potential Upside - DirectorsTalk Interviews
Should Doximity’s Shift From Russell Growth to Value Indices Require Action From DOCS Investors? - simplywall.st
Doximity, Inc. $DOCS Shares Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Price to earnings forward of Doximity, Inc. – NYSE:DOCS - TradingView
Doximity’s Shift Into Value Indices Might Change The Case For Investing In DOCS - Yahoo Finance
Doximity (DOCS) Stock Looks Cheap On Cash Flow But Fair On Earnings - Yahoo Finance
Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Doximity (DOCS) Stock Moves 1.25%: What You Should Know - Yahoo Finance
Is It Too Late to Buy Doximity Inc (DOCS) After 4.1% Rally? GF V - GuruFocus
Q2 Holdings, RingCentral, and Doximity Shares Skyrocket, What You Need To Know - Yahoo Finance
Doximity: Everyone Is Focused On The Guidance While Missing The Valuation And AI Stories - Seeking Alpha
Doximity, Inc.(NYSE: DOCS) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Doximity, Inc.(NYSE: DOCS) dropped from Russell 2500 Growth Benchmark - marketscreener.com
What's Going On With Doximity Stock Monday?Doximity (NYSE:DOCS) - Benzinga
Doximity, Inc.(NYSE: DOCS) added to Russell Midcap Value Benchmark - marketscreener.com
Doximity, Inc. Stock 12‑Month Price Target Cut to $24.27, Implies 16% Upside - TradingView
Doximity, Inc.(NYSE: DOCS) dropped from Russell Midcap Growth Benchmark - marketscreener.com
Doximity downgraded by BofA on AI investment concerns, margin pressure By Investing.com - Investing.com Canada
Doximity Facing Limited Clarity on AI Projects, BofA Says - Moomoo
Doximity, Inc.(NYSE: DOCS) dropped from Russell 1000 Growth-Defensive Index - marketscreener.com
Doximity downgraded by BofA on AI investment concerns, margin pressure - Yahoo Finance
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Comcast, Viridian Therapeutics jump premarket; Doximity slips By Investing.com - Investing.com Canada
BofA Securities Downgrades Doximity(DOCS.US) to Sell Rating, Cuts Target Price to $20 - Moomoo
Doximity Inc : BofA Global Research Cuts to U - Moomoo
Why is Doximity stock sliding today? By Investing.com - Investing.com Canada
Doximity, Inc.(NYSE: DOCS) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Doximity, Inc. $DOCS Shares Purchased by Fort Washington Investment Advisors Inc. OH - MarketBeat
Doximity, Inc.(NYSE: DOCS) added to Russell 1000 Value Benchmark - marketscreener.com
Doximity, Inc.(NYSE: DOCS) dropped from Russell 1000 Growth Benchmark - marketscreener.com
Doximity, Inc.(NYSE: DOCS) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Hsbc Holdings PLC Boosts Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc.(NYSE: DOCS) added to Russell 1000 Value-Defensive Index - marketscreener.com
Price to earnings forward of Doximity, Inc. – BOATS:DOCS - TradingView
Doximity (DOCS) sees a more significant dip than broader market: Some facts to know - MSN
Doximity, Inc. Class A Actuals & Estimates (NYSE:DOCS) - TradingView
Doximity, Inc. Class A Actuals & Estimates (BX:DOCS) - TradingView
Is Doximity (DOCS) Rerating Its AI Healthcare Story Amid EPS Pressure And Valuation Discount? - Sahm
Doximity Inc (DOCS) Shares Fall 4.7% -- What GF Score of 82 Tells Investors - GuruFocus
Doximity (DOCS) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Doximity, Inc. Class A Actuals & Estimates (BMV:DOCS1) - TradingView
Doximity(DOCS) Stock Options Chain | Quotes & News - Moomoo
Doximity Faces Continued Softness in Pharma Marketing Spending, RBC Capital Markets Says - Moomoo
J.P. Morgan Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $26 - Moomoo
DOCS Forecast — Price Target — Prediction for 2027 - TradingView
JPMorgan reiterates Doximity stock Neutral rating with $26 target By Investing.com - Investing.com Australia
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
Doximity price target lowered to $26 from $28 at JPMorgan - TipRanks
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.53%
2.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):